AML |
Acute myeloid leukemia |
ASO |
Antisense oligonucleotides |
ATR |
Ataxia telangiectasia and Rad3-related protein |
B-NHL |
B-cell non-Hodgkin lymphoma |
BP |
Branch point |
CLK |
CDC2-like kinase |
CLL |
Chronic lymphocytic leukemia |
CP |
Cleavage and polyadenylation |
EJCs |
Exon junction complexes |
ESEs |
Exonic splicing enhancers |
ESSs |
Exonic splicing silencers |
HCC |
Hepatocellular carcinoma |
hnRNPs |
Heterogeneous nuclear ribonucleoproteins |
ISEs |
Intronic splicing enhancers |
ISSs |
Intronic splicing silencers |
MB |
Medulloblastoma |
MDS |
Myelodysplastic syndrome |
METTL3 |
N6-adenosine methyltransferase |
NMD |
Nonsense-mediated mRNA decay |
PC |
Pancreatic adenocarcinoma |
PPT |
Polypyrimidine tract |
PTCs |
Premature termination codons |
PRMT5 |
Protein arginine N-methyltransferase 5 |
PKM |
Pyruvate kinase |
RNPs |
Ribonucleoproteins |
RRM |
RNA-recognition motif |
SRPK |
SR protein kinase family |
snRNPs |
Small nuclear ribonucleoproteins |
SS |
Splice site |